World News: 12:30 GMT Tuesday 28th August 2018. [Zai Lab Limited via Globe Newswire via SPi World News]
SHANGHAI China Aug 28 2018 GLOBE NEWSWIRE -- Zai LabNASDAQ ZLAB a Shanghai-based innovative biopharmaceutical company today dosing of the first patient in a Phase III trial of niraparib in patients with smal l-cell ...
Globe Newswire: 12:30 GMT Tuesday 28th August 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.